Biomarkers are no longer just exploratory tools-they're becoming strategic assets in drug development and clinical trials. Join a panel of industry thought leaders as they explore how biomar...
Explore how super-resolution microscopy reveals GPCR and RTK receptor dimerization, with a focus on D2 dopamine receptor function and disease relevance....
Antibody-drug conjugates (ADCs) represent the most successful class of active targeting drug-delivery systems, however, despite the increasing number of FDA approvals treatment-related adver...
DATE: April 17, 2019TIME: 9:00am PDT...
DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
Date: June 16, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) Lipid-based nanoparticles (LNPs) are effective non-viral vectors for delivering messenger RNA products (mRNA), most notab...
DATE: February 26, 2019TIME: 9:00am PST, 12:00pm EST In an era of increasingly high-throughput, large-scale biology, with companies, government and non-prof...
DATE: September 19, 2017TIME: 10:30am PDT/ 1:30pm EDT/ 7:30pm CESTPart 1 – Cigall Kadoch, Ph.D. (30 min.)Exome- and genome-wide sequencing studies in human cancer have...